Explore

Trendline Trendline
Enanta Pharmaceuticals Reports Q2 2026 Financial Results Highlighting Revenue Growth and Strategic Developments

Enanta Pharmaceuticals Reports Q2 2026 Financial Results Highlighting Revenue Growth and Strategic Developments

Enanta Pharmaceuticals Reports Q2 2026 Financial Results Highlighting Revenue Growth and Strategic Developments
Trendline Trendline
Enanta Pharmaceuticals Reports Decreased Net Loss Amid Financial Results for Q2 2026

Enanta Pharmaceuticals Reports Decreased Net Loss Amid Financial Results for Q2 2026

Enanta Pharmaceuticals Reports Decreased Net Loss Amid Financial Results for Q2 2026
Trendline Trendline
Enanta Pharmaceuticals Reports Q2 Financial Results and Advances Clinical Programs

Enanta Pharmaceuticals Reports Q2 Financial Results and Advances Clinical Programs

Enanta Pharmaceuticals Reports Q2 Financial Results and Advances Clinical Programs
Trendline Trendline
Veradermics Reports Q1 2026 Financial Results and Clinical Progress in Hair Loss Treatment

Veradermics Reports Q1 2026 Financial Results and Clinical Progress in Hair Loss Treatment

Veradermics Reports Q1 2026 Financial Results and Clinical Progress in Hair Loss Treatment
Trendline Trendline
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call
Trendline Trendline
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments
Trendline Trendline
AN2 Therapeutics Advances Multiple Drug Programs with New Phase 2 Trials

AN2 Therapeutics Advances Multiple Drug Programs with New Phase 2 Trials

AN2 Therapeutics Advances Multiple Drug Programs with New Phase 2 Trials
Trendline Trendline
Alnylam Pharmaceuticals Presents New Data on Vutrisiran's Efficacy for ATTR-CM Patients

Alnylam Pharmaceuticals Presents New Data on Vutrisiran's Efficacy for ATTR-CM Patients

Alnylam Pharmaceuticals Presents New Data on Vutrisiran's Efficacy for ATTR-CM Patients
Trendline Trendline
AI and Biotechnology Convergence Drives Personalized Medicine Advancements

AI and Biotechnology Convergence Drives Personalized Medicine Advancements

AI and Biotechnology Convergence Drives Personalized Medicine Advancements
Trendline Trendline
Verastem Oncology to Present at Key Investor Conferences in May 2026

Verastem Oncology to Present at Key Investor Conferences in May 2026

Verastem Oncology to Present at Key Investor Conferences in May 2026
Trendline Trendline
Savara Inc. to Participate in BioConnect Investor Conference, Highlighting Rare Respiratory Disease Focus

Savara Inc. to Participate in BioConnect Investor Conference, Highlighting Rare Respiratory Disease Focus

Savara Inc. to Participate in BioConnect Investor Conference, Highlighting Rare Respiratory Disease Focus
Trendline Trendline
Rosen Law Firm Investigates Immutep Ltd. for Securities Class Action

Rosen Law Firm Investigates Immutep Ltd. for Securities Class Action

Rosen Law Firm Investigates Immutep Ltd. for Securities Class Action